Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others), By Application (Oncology, Cardiovascular Diseases, Neurological Disorders), By Company and By Region
December 1, 2022
TechSci Research
117
PDF
Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others), By Application (Oncology, Cardiovascular Diseases, Neurological Disorders), By Company and By Region
Abstract The global computer aided detection market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of chronic diseases and technological advancements, which are bolstering the growth of the market, globally. Computer aided detection (CAD) is a group of algorithms that use pattern identification to help physicians understand medical images. The computer aided detection software helps in the early diagnosis of various diseases such as cardiovascular diseases, cancer, chronic diseases, and neurological diseases through the imaging modalities, such as magnetic resonance imaging, x-rays imaging, ultrasound imaging, and computed tomography. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the gradual surge in demand for health insurance and medical tourism are some of the key factors that are projected to bolster the market growth. Rising Prevalence of Chronic Diseases Rising incidence of various chronic diseases such as stroke, various types of cancers, cardiovascular disorders, and neurological dysfunctions are increasing the demand of computer-aided detection, which propels the market growth, globally. Owing to the rapid change in lifestyles and environment, the number of cancer cases such as lung cancer, cervical cancer, breast cancer, prostate, and leukemia, are rising which enables the need for CAD. According to WHO, there is a probability of a 30% rise in the number of cancer cases by 2038. Computer-aided detection system assist doctors to detect cancer at early stages, reduce mortality rates for cancer and other diseases and also helps in decreasing the false negative rate, due to which people and multispecialty hospitals are opting for diagnostic imaging techniques. Thus, in turn, bolstering the growth of the market. According to the CDC, in the U.S., roughly 210,828 people were detected with lung cancer, including 99,433 women and 111,395 men. Also, in the U.S., 157,423 people died from lung cancer. Furthermore, due to the growing awareness among the patients about successful cancer treatment, is also a contributing factor for the growth of the market. Technological Advancements and Increasing Investments Over the past few years, rapid technological advancements are done in healthcare sector, which propels the market growth. Technological advancements like evolution of artificial intelligence (AI) and increase in sensitivity are projected to strengthen the continuous development of the global CAD market. For instance, in 2020, a study in work with data sets from the U.S. and the United Kingdom (U.K.) revealed that the AI model was able to successfully screen for breast cancer using only the pixel data given. Medical researchers and physicians are using medical imaging devices which are coupled with computer aided detection. Owing to the demand for error free detection, the demand for computational assistance is rising. Therefore, advanced digital imaging techniques are being improved for the better effectiveness and efficiencies of CAD solutions. In addition to these, major investments in R&D of computer aided detection with 3D imaging is augmenting the growth of the market.
Market Segmentation The global computer aided detection market is segmented into imaging modality, application, and company. Based on imaging modality, the market is divided into mammography, MRI, ultrasound, tomosynthesis, and others. Based on application, the market is divided into oncology, cardiovascular diseases, and neurological disorders. Based on oncology, the market is further divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidence of various types of cancer in the country. Market Players Hologic Inc., GE Healthcare, Agfa-Gevaert N.V, iCAD, Inc., Invivo Corporation, McKesson Corporation, Siemens Healthineers AG, EDDA technology, Inc., FUJIFILM Medical Systems U.S.A., Inc., and Koninklijke Philips N.V. are some of the leading companies operating in the market.
Report Scope: In this report, global computer aided detection market has been segmented into following categories, in addition to the industry trends which have also been detailed below: •Computer Aided Detection Market, By Imaging Modality: oMammography oMRI oUltrasound oTomosynthesis oOthers •Computer Aided Detection Market, By Application: oOncology Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Others oCardiovascular Diseases oNeurological Disorders •Computer Aided Detection Market, By Region: oNorth America United States Canada Mexico oAsia-Pacific China India Japan Australia South Korea oEurope & CIS Germany France United Kingdom Spain Italy oSouth America Brazil Argentina Colombia oMiddle East & Africa South Africa Saudi Arabia UAE Competitive Landscape
Competitive Landscape Detailed analysis of the major companies present in computer aided detection market
Available Customizations: With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report: Company Information •Detailed analysis and profiling of additional market players (up to five).
Content Table of Contents
1.Product Overview 2.Research Methodology 3.Impact of COVID-19 on Global Computer Aided Detection Market 4.Voice of Customer 5.Executive Summary 6.Global Computer Aided Detection Market Outlook 6.1.Market Size & Forecast 6.1.1.By Value 6.2.Market Share & Forecast 6.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 6.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 6.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 6.2.3.By Company (2021) 6.2.4.By Region 6.3.Market Map 7.North America Computer Aided Detection Market Outlook 7.1.Market Size & Forecast 7.1.1.By Value 7.2.Market Share & Forecast 7.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 7.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 7.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 7.2.3.By Country 7.3.North America: Country Analysis 7.3.1.United States Computer Aided Detection Market Outlook 7.3.1.1.Market Size & Forecast 7.3.1.1.1.By Value 7.3.1.2.Market Share & Forecast 7.3.1.2.1.By Imaging Modality 7.3.1.2.2.By Application 7.3.2.Mexico Computer Aided Detection Market Outlook 7.3.2.1.Market Size & Forecast 7.3.2.1.1.By Value 7.3.2.2.Market Share & Forecast 7.3.2.2.1.By Imaging Modality 7.3.2.2.2.By Application 7.3.3.Canada Computer Aided Detection Market Outlook 7.3.3.1.Market Size & Forecast 7.3.3.1.1.By Value 7.3.3.2.Market Share & Forecast 7.3.3.2.1.By Imaging Modality 7.3.3.2.2.By Application 8.Europe Computer Aided Detection Market Outlook 8.1.Market Size & Forecast 8.1.1.By Value 8.2.Market Share & Forecast 8.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 8.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 8.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 8.2.3.By Country 8.3.Europe: Country Analysis 8.3.1.France Computer Aided Detection Market Outlook 8.3.1.1.Market Size & Forecast 8.3.1.1.1.By Value 8.3.1.2.Market Share & Forecast 8.3.1.2.1.By Imaging Modality 8.3.1.2.2.By Application 8.3.2.Germany Computer Aided Detection Market Outlook 8.3.2.1.Market Size & Forecast 8.3.2.1.1.By Value 8.3.2.2.Market Share & Forecast 8.3.2.2.1.By Imaging Modality 8.3.2.2.2.By Application 8.3.3.United Kingdom Computer Aided Detection Market Outlook 8.3.3.1.Market Size & Forecast 8.3.3.1.1.By Value 8.3.3.2.Market Share & Forecast 8.3.3.2.1.By Imaging Modality 8.3.3.2.2.By Application 8.3.4.Italy Computer Aided Detection Market Outlook 8.3.4.1.Market Size & Forecast 8.3.4.1.1.By Value 8.3.4.2.Market Share & Forecast 8.3.4.2.1.By Imaging Modality 8.3.4.2.2.By Application 8.3.5.Spain Computer Aided Detection Market Outlook 8.3.5.1.Market Size & Forecast 8.3.5.1.1.By Value 8.3.5.2.Market Share & Forecast 8.3.5.2.1.By Imaging Modality 8.3.5.2.2.By Application 9.Asia-Pacific Computer Aided Detection Market Outlook 9.1.Market Size & Forecast 9.1.1.By Value 9.2.Market Share & Forecast 9.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 9.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 9.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 9.2.3.By Country 9.3.Asia-Pacific: Country Analysis 9.3.1.China Computer Aided Detection Market Outlook 9.3.1.1.Market Size & Forecast 9.3.1.1.1.By Value 9.3.1.2.Market Share & Forecast 9.3.1.2.1.By Imaging Modality 9.3.1.2.2.By Application 9.3.2.India Computer Aided Detection Market Outlook 9.3.2.1.Market Size & Forecast 9.3.2.1.1.By Value 9.3.2.2.Market Share & Forecast 9.3.2.2.1.By Imaging Modality 9.3.2.2.2.By Application 9.3.3.Japan Computer Aided Detection Market Outlook 9.3.3.1.Market Size & Forecast 9.3.3.1.1.By Value 9.3.3.2.Market Share & Forecast 9.3.3.2.1.By Imaging Modality 9.3.3.2.2.By Application 9.3.4.South Korea Computer Aided Detection Market Outlook 9.3.4.1.Market Size & Forecast 9.3.4.1.1.By Value 9.3.4.2.Market Share & Forecast 9.3.4.2.1.By Imaging Modality 9.3.4.2.2.By Application 9.3.5.Australia Computer Aided Detection Market Outlook 9.3.5.1.Market Size & Forecast 9.3.5.1.1.By Value 9.3.5.2.Market Share & Forecast 9.3.5.2.1.By Imaging Modality 9.3.5.2.2.By Application 10.South America Computer Aided Detection Market Outlook 10.1.Market Size & Forecast 10.1.1.By Value 10.2.Market Share & Forecast 10.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 10.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 10.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 10.2.3.By Country 10.3.South America: Country Analysis 10.3.1.Brazil Computer Aided Detection Market Outlook 10.3.1.1.Market Size & Forecast 10.3.1.1.1.By Value 10.3.1.2.Market Share & Forecast 10.3.1.2.1.By Imaging Modality 10.3.1.2.2.By Application 10.3.2.Argentina Computer Aided Detection Market Outlook 10.3.2.1.Market Size & Forecast 10.3.2.1.1.By Value 10.3.2.2.Market Share & Forecast 10.3.2.2.1.By Imaging Modality 10.3.2.2.2.By Application 10.3.3.Colombia Computer Aided Detection Market Outlook 10.3.3.1.Market Size & Forecast 10.3.3.1.1.By Value 10.3.3.2.Market Share & Forecast 10.3.3.2.1.By Imaging Modality 10.3.3.2.2.By Application 11.Middle East and Africa Computer Aided Detection Market Outlook 11.1.Market Size & Forecast 11.1.1.By Value 11.2.Market Share & Forecast 11.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 11.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 11.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 11.2.3.By Country 11.3.MEA: Country Analysis 11.3.1.South Africa Computer Aided Detection Market Outlook 11.3.1.1.Market Size & Forecast 11.3.1.1.1.By Value 11.3.1.2.Market Share & Forecast 11.3.1.2.1.By Imaging Modality 11.3.1.2.2.By Application 11.3.2.Saudi Arabia Computer Aided Detection Market Outlook 11.3.2.1.Market Size & Forecast 11.3.2.1.1.By Value 11.3.2.2.Market Share & Forecast 11.3.2.2.1.By Imaging Modality 11.3.2.2.2.By Application 11.3.3.UAE Computer Aided Detection Market Outlook 11.3.3.1.Market Size & Forecast 11.3.3.1.1.By Value 11.3.3.2.Market Share & Forecast 11.3.3.2.1.By Imaging Modality 11.3.3.2.2.By Application 12.Market Dynamics 12.1.Drivers 12.2.Challenges 13.Market Trends & Developments 14.Competitive Landscape 14.1.Hologic Inc. 14.2.GE Healthcare 14.3.Agfa-Gevaert N.V 14.4.iCAD, Inc. 14.5.Invivo Corporation 14.6.McKesson Corporation 14.7.Siemens Healthineers AG 14.8.EDDA technology, Inc. 14.9.FUJIFILM Medical Systems U.S.A., Inc. 14.10.Koninklijke Philips N.V. 15.Strategic Recommendations
The global computer aided detection market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of chronic diseases and technological advancements, which are bolstering the growth of the market, globally. Computer aided detection (CAD) is a group of algorithms that use pattern identification to help physicians understand medical images. The computer aided detection software helps in the early diagnosis of various diseases such as cardiovascular diseases, cancer, chronic diseases, and neurological diseases through the imaging modalities, such as magnetic resonance imaging, x-rays imaging, ultrasound imaging, and computed tomography. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the gradual surge in demand for health insurance and medical tourism are some of the key factors that are projected to bolster the market growth. Rising Prevalence of Chronic Diseases Rising incidence of various chronic diseases such as stroke, various types of cancers, cardiovascular disorders, and neurological dysfunctions are increasing the demand of computer-aided detection, which propels the market growth, globally. Owing to the rapid change in lifestyles and environment, the number of cancer cases such as lung cancer, cervical cancer, breast cancer, prostate, and leukemia, are rising which enables the need for CAD. According to WHO, there is a probability of a 30% rise in the number of cancer cases by 2038. Computer-aided detection system assist doctors to detect cancer at early stages, reduce mortality rates for cancer and other diseases and also helps in decreasing the false negative rate, due to which people and multispecialty hospitals are opting for diagnostic imaging techniques. Thus, in turn, bolstering the growth of the market. According to the CDC, in the U.S., roughly 210,828 people were detected with lung cancer, including 99,433 women and 111,395 men. Also, in the U.S., 157,423 people died from lung cancer. Furthermore, due to the growing awareness among the patients about successful cancer treatment, is also a contributing factor for the growth of the market. Technological Advancements and Increasing Investments Over the past few years, rapid technological advancements are done in healthcare sector, which propels the market growth. Technological advancements like evolution of artificial intelligence (AI) and increase in sensitivity are projected to strengthen the continuous development of the global CAD market. For instance, in 2020, a study in work with data sets from the U.S. and the United Kingdom (U.K.) revealed that the AI model was able to successfully screen for breast cancer using only the pixel data given. Medical researchers and physicians are using medical imaging devices which are coupled with computer aided detection. Owing to the demand for error free detection, the demand for computational assistance is rising. Therefore, advanced digital imaging techniques are being improved for the better effectiveness and efficiencies of CAD solutions. In addition to these, major investments in R&D of computer aided detection with 3D imaging is augmenting the growth of the market.
Market Segmentation The global computer aided detection market is segmented into imaging modality, application, and company. Based on imaging modality, the market is divided into mammography, MRI, ultrasound, tomosynthesis, and others. Based on application, the market is divided into oncology, cardiovascular diseases, and neurological disorders. Based on oncology, the market is further divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidence of various types of cancer in the country. Market Players Hologic Inc., GE Healthcare, Agfa-Gevaert N.V, iCAD, Inc., Invivo Corporation, McKesson Corporation, Siemens Healthineers AG, EDDA technology, Inc., FUJIFILM Medical Systems U.S.A., Inc., and Koninklijke Philips N.V. are some of the leading companies operating in the market.
Report Scope: In this report, global computer aided detection market has been segmented into following categories, in addition to the industry trends which have also been detailed below: •Computer Aided Detection Market, By Imaging Modality: oMammography oMRI oUltrasound oTomosynthesis oOthers •Computer Aided Detection Market, By Application: oOncology Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Others oCardiovascular Diseases oNeurological Disorders •Computer Aided Detection Market, By Region: oNorth America United States Canada Mexico oAsia-Pacific China India Japan Australia South Korea oEurope & CIS Germany France United Kingdom Spain Italy oSouth America Brazil Argentina Colombia oMiddle East & Africa South Africa Saudi Arabia UAE Competitive Landscape
Competitive Landscape Detailed analysis of the major companies present in computer aided detection market
Available Customizations: With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report: Company Information •Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1.Product Overview 2.Research Methodology 3.Impact of COVID-19 on Global Computer Aided Detection Market 4.Voice of Customer 5.Executive Summary 6.Global Computer Aided Detection Market Outlook 6.1.Market Size & Forecast 6.1.1.By Value 6.2.Market Share & Forecast 6.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 6.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 6.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 6.2.3.By Company (2021) 6.2.4.By Region 6.3.Market Map 7.North America Computer Aided Detection Market Outlook 7.1.Market Size & Forecast 7.1.1.By Value 7.2.Market Share & Forecast 7.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 7.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 7.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 7.2.3.By Country 7.3.North America: Country Analysis 7.3.1.United States Computer Aided Detection Market Outlook 7.3.1.1.Market Size & Forecast 7.3.1.1.1.By Value 7.3.1.2.Market Share & Forecast 7.3.1.2.1.By Imaging Modality 7.3.1.2.2.By Application 7.3.2.Mexico Computer Aided Detection Market Outlook 7.3.2.1.Market Size & Forecast 7.3.2.1.1.By Value 7.3.2.2.Market Share & Forecast 7.3.2.2.1.By Imaging Modality 7.3.2.2.2.By Application 7.3.3.Canada Computer Aided Detection Market Outlook 7.3.3.1.Market Size & Forecast 7.3.3.1.1.By Value 7.3.3.2.Market Share & Forecast 7.3.3.2.1.By Imaging Modality 7.3.3.2.2.By Application 8.Europe Computer Aided Detection Market Outlook 8.1.Market Size & Forecast 8.1.1.By Value 8.2.Market Share & Forecast 8.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 8.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 8.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 8.2.3.By Country 8.3.Europe: Country Analysis 8.3.1.France Computer Aided Detection Market Outlook 8.3.1.1.Market Size & Forecast 8.3.1.1.1.By Value 8.3.1.2.Market Share & Forecast 8.3.1.2.1.By Imaging Modality 8.3.1.2.2.By Application 8.3.2.Germany Computer Aided Detection Market Outlook 8.3.2.1.Market Size & Forecast 8.3.2.1.1.By Value 8.3.2.2.Market Share & Forecast 8.3.2.2.1.By Imaging Modality 8.3.2.2.2.By Application 8.3.3.United Kingdom Computer Aided Detection Market Outlook 8.3.3.1.Market Size & Forecast 8.3.3.1.1.By Value 8.3.3.2.Market Share & Forecast 8.3.3.2.1.By Imaging Modality 8.3.3.2.2.By Application 8.3.4.Italy Computer Aided Detection Market Outlook 8.3.4.1.Market Size & Forecast 8.3.4.1.1.By Value 8.3.4.2.Market Share & Forecast 8.3.4.2.1.By Imaging Modality 8.3.4.2.2.By Application 8.3.5.Spain Computer Aided Detection Market Outlook 8.3.5.1.Market Size & Forecast 8.3.5.1.1.By Value 8.3.5.2.Market Share & Forecast 8.3.5.2.1.By Imaging Modality 8.3.5.2.2.By Application 9.Asia-Pacific Computer Aided Detection Market Outlook 9.1.Market Size & Forecast 9.1.1.By Value 9.2.Market Share & Forecast 9.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 9.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 9.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 9.2.3.By Country 9.3.Asia-Pacific: Country Analysis 9.3.1.China Computer Aided Detection Market Outlook 9.3.1.1.Market Size & Forecast 9.3.1.1.1.By Value 9.3.1.2.Market Share & Forecast 9.3.1.2.1.By Imaging Modality 9.3.1.2.2.By Application 9.3.2.India Computer Aided Detection Market Outlook 9.3.2.1.Market Size & Forecast 9.3.2.1.1.By Value 9.3.2.2.Market Share & Forecast 9.3.2.2.1.By Imaging Modality 9.3.2.2.2.By Application 9.3.3.Japan Computer Aided Detection Market Outlook 9.3.3.1.Market Size & Forecast 9.3.3.1.1.By Value 9.3.3.2.Market Share & Forecast 9.3.3.2.1.By Imaging Modality 9.3.3.2.2.By Application 9.3.4.South Korea Computer Aided Detection Market Outlook 9.3.4.1.Market Size & Forecast 9.3.4.1.1.By Value 9.3.4.2.Market Share & Forecast 9.3.4.2.1.By Imaging Modality 9.3.4.2.2.By Application 9.3.5.Australia Computer Aided Detection Market Outlook 9.3.5.1.Market Size & Forecast 9.3.5.1.1.By Value 9.3.5.2.Market Share & Forecast 9.3.5.2.1.By Imaging Modality 9.3.5.2.2.By Application 10.South America Computer Aided Detection Market Outlook 10.1.Market Size & Forecast 10.1.1.By Value 10.2.Market Share & Forecast 10.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 10.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 10.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 10.2.3.By Country 10.3.South America: Country Analysis 10.3.1.Brazil Computer Aided Detection Market Outlook 10.3.1.1.Market Size & Forecast 10.3.1.1.1.By Value 10.3.1.2.Market Share & Forecast 10.3.1.2.1.By Imaging Modality 10.3.1.2.2.By Application 10.3.2.Argentina Computer Aided Detection Market Outlook 10.3.2.1.Market Size & Forecast 10.3.2.1.1.By Value 10.3.2.2.Market Share & Forecast 10.3.2.2.1.By Imaging Modality 10.3.2.2.2.By Application 10.3.3.Colombia Computer Aided Detection Market Outlook 10.3.3.1.Market Size & Forecast 10.3.3.1.1.By Value 10.3.3.2.Market Share & Forecast 10.3.3.2.1.By Imaging Modality 10.3.3.2.2.By Application 11.Middle East and Africa Computer Aided Detection Market Outlook 11.1.Market Size & Forecast 11.1.1.By Value 11.2.Market Share & Forecast 11.2.1.By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others) 11.2.2.By Application (Oncology, Cardiovascular Diseases, Neurological Disorders) 11.2.2.1.By Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others) 11.2.3.By Country 11.3.MEA: Country Analysis 11.3.1.South Africa Computer Aided Detection Market Outlook 11.3.1.1.Market Size & Forecast 11.3.1.1.1.By Value 11.3.1.2.Market Share & Forecast 11.3.1.2.1.By Imaging Modality 11.3.1.2.2.By Application 11.3.2.Saudi Arabia Computer Aided Detection Market Outlook 11.3.2.1.Market Size & Forecast 11.3.2.1.1.By Value 11.3.2.2.Market Share & Forecast 11.3.2.2.1.By Imaging Modality 11.3.2.2.2.By Application 11.3.3.UAE Computer Aided Detection Market Outlook 11.3.3.1.Market Size & Forecast 11.3.3.1.1.By Value 11.3.3.2.Market Share & Forecast 11.3.3.2.1.By Imaging Modality 11.3.3.2.2.By Application 12.Market Dynamics 12.1.Drivers 12.2.Challenges 13.Market Trends & Developments 14.Competitive Landscape 14.1.Hologic Inc. 14.2.GE Healthcare 14.3.Agfa-Gevaert N.V 14.4.iCAD, Inc. 14.5.Invivo Corporation 14.6.McKesson Corporation 14.7.Siemens Healthineers AG 14.8.EDDA technology, Inc. 14.9.FUJIFILM Medical Systems U.S.A., Inc. 14.10.Koninklijke Philips N.V. 15.Strategic Recommendations